The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo

Enterovirus 71 (EV71) causes severe central nervous system infections, leading to cardiopulmonary complications and death in young children. There is an urgent unmet medical need for new pharmaceutical agents to control EV71 infections. Using a multidisciplinary approach, we found that the approved...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ren, Peijun, Zou, Gang, Bailly, Benjamin, Xu, Shanshan, Zeng, Mei, Chen, Xinsheng, Shen, Liang, Zhang, Ying, Guillon, Patrice, Arenzana-Seisdedos, Fernando, Buchy, Philippe, Li, Jian, von Itzstein, Mark, Li, Qihan, Altmeyer, Ralf
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2014
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185360/
https://ncbi.nlm.nih.gov/pubmed/26038755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2014.60
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak